Table 2. Pharmacokinetic parameters of recombinant anti-ErbB2 antibodies in mice.
Trastuzumab-biotin-based competitive ELISA | Pertuzumab-biotin-based competitive ELISA | |||||
---|---|---|---|---|---|---|
Parametera | Trastuzumab | F0178 | F0179 | Pertuzumab | F0178 | F0179 |
AUC (day μg ml−1) | 419.91 | 399.23 | 389.12 | 312.56 | 321.67 | 331.87 |
T1/2(day) | 6.12 | 6.14 | 6.57 | 7.11 | 6.89 | 6.37 |
CL (ml day−1 kg−1) | 11.15 | 10.91 | 11.50 | 10.11 | 9.89 | 10.04 |
VSS(ml kg−1) | 55.78 | 56.89 | 59.33 | 50.14 | 48.15 | 51.44 |
a Pharmacokinetic parameters were calculated using a noncompartmental analysis. AUC, area under the concentration vs. time curve; t1/2, half-life; CL, clearance; VSS, steady-state volume of distribution.